# A Prospective, Randomized, Single-blinded (Evaluator), Parallel, Multi-center, Phase 3 Trial in Bowel Preparation for Colonoscopy

> **NCT03544944** · PHASE3 · COMPLETED · sponsor: **Taejoon Pharmaceutical Co., Ltd.** · enrollment: 297 (actual)

## Conditions studied

- Bowel Preparation

## Interventions

- **DRUG:** TJP-008-1
- **DRUG:** TJP-008-2
- **DRUG:** Coolprep powder

## Key facts

- **NCT ID:** NCT03544944
- **Lead sponsor:** Taejoon Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-01-02
- **Primary completion:** 2018-05-30
- **Final completion:** 2018-07-30
- **Target enrollment:** 297 (ACTUAL)
- **Last updated:** 2019-09-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03544944

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03544944, "A Prospective, Randomized, Single-blinded (Evaluator), Parallel, Multi-center, Phase 3 Trial in Bowel Preparation for Colonoscopy". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03544944. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*